EdgarLookup

Dare Bioscience, Inc. — All Filings

724 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 1-A 1-A/A 10-K 10-K/A 10-Q 10-Q/A 253G1 3 3/A 4 4/A 424B3 424B4 424B5 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D D/A DEF 14A DEFA14A DEFM14A DFAN14A DRS EFFECT FWP POS AM PRE 14A PREM14A PRER14A QUALIF REGDEX S-1 S-1/A S-3 S-3/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
CORRESP 0001193125-17-206418 Jun 19, 2017
DEFM14A DEFM14A 0001193125-17-206412 Jun 19, 2017
UPLOAD 0000000000-17-021087 Jun 15, 2017
CORRESP 0001193125-17-202516 Jun 13, 2017
PRER14A PRER14A 0001193125-17-202510 Jun 13, 2017
10-Q/A 10-Q/A 0001193125-17-202485 Jun 13, 2017 Mar 31, 2017
10-K/A 10-K/A 0001193125-17-202472 Jun 13, 2017 Dec 31, 2016
8-K FORM 8-K 0001193125-17-200205 Jun 9, 2017 Jun 6, 2017
UPLOAD 0000000000-17-020195 Jun 9, 2017
8-K 8-K 0001193125-17-193731 Jun 5, 2017 Jun 1, 2017
8-K 8-K 0001193125-17-190265 Jun 1, 2017 May 31, 2017
CORRESP 0001193125-17-185556 May 26, 2017
PRER14A PRER14A 0001193125-17-185541 May 26, 2017
8-K 8-K 0001193125-17-176786 May 19, 2017
UPLOAD 0000000000-17-016987 May 15, 2017
10-Q FORM 10-Q 0001193125-17-168585 May 12, 2017 Mar 31, 2017
8-K FORM 8-K 0001193125-17-162658 May 8, 2017
DEFA14A FORM 8-K 0001193125-17-162661 May 8, 2017
8-K FORM 8-K 0001193125-17-160962 May 5, 2017
10-K/A 10-K/A 0001564590-17-007681 Apr 28, 2017 Dec 31, 2016
PREM14A PREM14A 0001193125-17-125987 Apr 17, 2017
8-K FORM 8-K 0001193125-17-125978 Apr 17, 2017
4 FORM 4 SUBMISSION 0001209191-17-025668 Apr 5, 2017 Apr 3, 2017
10-K 10-K 0001564590-17-005798 Mar 31, 2017 Dec 31, 2016
SC 13D SC 13D 0001193125-17-099723 Mar 28, 2017
8-K FORM 8-K 0001193125-17-094960 Mar 24, 2017 Mar 23, 2017
DEFA14A FORM 8-K 0001193125-17-094961 Mar 24, 2017
8-K FORM 8-K 0001193125-17-090764 Mar 21, 2017 Mar 20, 2017
DEFA14A FORM 8-K 0001193125-17-090765 Mar 21, 2017
8-K 8-K 0001193125-17-088279 Mar 20, 2017 Mar 19, 2017
DEFA14A 8-K 0001193125-17-088280 Mar 20, 2017
SC 13G/A SCHEDULE 13G (AMENDMENT NO. 1) 0001571049-17-001322 Feb 14, 2017
SC 13G/A SCHEDULE 13G AMENDMENT NO. 2 0000913849-17-000035 Feb 10, 2017
3/A FORM 3/A SUBMISSION 0001209191-17-004484 Jan 19, 2017 Oct 25, 2016
4 FORM 4 SUBMISSION 0001209191-17-002984 Jan 9, 2017 Jan 5, 2017
4 FORM 4 SUBMISSION 0001209191-17-002981 Jan 9, 2017 Jan 5, 2017
4 FORM 4 SUBMISSION 0001209191-17-002978 Jan 9, 2017 Jan 6, 2017
4 FORM 4 SUBMISSION 0001209191-17-002976 Jan 9, 2017 Jan 5, 2017
4 FORM 4 SUBMISSION 0001209191-17-002973 Jan 9, 2017 Jan 5, 2017
4 FORM 4 SUBMISSION 0001209191-17-002970 Jan 9, 2017 Jan 5, 2017
4 FORM 4 SUBMISSION 0001209191-17-002084 Jan 5, 2017 Jan 3, 2017
4 FORM 4 SUBMISSION 0001209191-17-002082 Jan 5, 2017 Jan 3, 2017
4 FORM 4 SUBMISSION 0001209191-17-002079 Jan 5, 2017 Jan 3, 2017
4 FORM 4 SUBMISSION 0001209191-17-002074 Jan 5, 2017 Jan 3, 2017
4 FORM 4 SUBMISSION 0001209191-17-002068 Jan 5, 2017 Dec 31, 2016
4 FORM 4 SUBMISSION 0001209191-17-002055 Jan 5, 2017 Jan 3, 2017
4 FORM 4 SUBMISSION 0001209191-17-002049 Jan 5, 2017 Jan 3, 2017
CT ORDER 9999999997-17-000034 Jan 5, 2017
CT ORDER 9999999997-16-027773 Dec 15, 2016
8-K 8-K - NASDAQ 0001564590-16-029464 Nov 18, 2016 Nov 17, 2016